Clinical Trials List
2011-06-15 - 2013-04-30
Phase III
Terminated6
ICD-10B17.10
Acute hepatitis C without hepatic coma
ICD-10B19.20
Unspecified viral hepatitis C without hepatic coma
ICD-9070.51
Hepatitis C without mention of hepatic coma, acute or unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ming-Lun Yeh Digestive System Department
- Chia-Yen Dai Digestive System Department
- Ming-Lung Yu Digestive System Department
- Jee-Fu Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 趙景華 Digestive System Department
- 曾柏霖 Digestive System Department
- 李全膜 Digestive System Department
- Jing-Houng Wang Digestive System Department
- 張國欽 Digestive System Department
- 洪肇宏 Digestive System Department
- 蔡明釗 Digestive System Department
- 邱世賢 Digestive System Department
- 童維智 Digestive System Department
- 郭垣宏 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 酆裕民 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chen-Hua Liu Digestive System Department
- 陳介章 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蘇文邦 Division of General Internal Medicine
- 高榮達 Division of General Internal Medicine
- Hsueh-Chou Lai Division of General Internal Medicine
- 陳昇弘 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- PEI-JER CHEN Digestive System Department
- 楊宏志 Digestive System Department
- Chien-Hung Chen Digestive System Department
- 蘇東弘 Digestive System Department
- Chun-Jen Liu Digestive System Department
- Chen-Hua Liu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1040 participants
